{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:48:53Z","timestamp":1791931733238,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T00:00:00Z","timestamp":1509753600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00223-017-0357-1","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T10:15:46Z","timestamp":1509790546000},"page":"368-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiple Vertebral Osteonecroses (K\u00fcmmell\u2019s Disease) After 10\u00a0Years on Denosumab: Is Osteocyte Apoptosis to Blame?"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-8524","authenticated-orcid":false,"given":"Yves","family":"Maugars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Chemel-Mary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Gl\u00e9marec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Gahier-Penhoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Darrieutort-Laffite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,4]]},"reference":[{"key":"357_CR1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jbmr.2693","volume":"31","author":"X Zhang","year":"2016","unstructured":"Zhang X, Hamadeh IS, Song S et al (2016) Osteonecrosis of the jaw in the United States Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS). J Bone Miner Res 31:336\u2013340","journal-title":"J Bone Miner Res"},{"key":"357_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3458-6","author":"AW Popp","year":"2016","unstructured":"Popp AW, Zysset PK, Lippuner K (2016) Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics. Osteoporos Int. \n                        https:\/\/doi.org\/10.1007\/s00198-015-3458-6","journal-title":"Osteoporos Int"},{"key":"357_CR3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00198-015-3459-5","volume":"27","author":"AD Anastasilakis","year":"2016","unstructured":"Anastasilakis AD, Makras P (2016) Multiple clinical vertebral fractures following denosumab discontinuation. Osteoporos Int 27:1929","journal-title":"Osteoporos Int"},{"key":"357_CR4","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00198-015-3380-y","volume":"27","author":"B Aubry-Rozier","year":"2016","unstructured":"Aubry-Rozier B, Gonzalez-Rodriguez E, Stoll D et al (2016) Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports. Osteoporos Int 27:1923\u20131925","journal-title":"Osteoporos Int"},{"key":"357_CR5","first-page":"1929","volume":"27","author":"SA Polyzos","year":"2016","unstructured":"Polyzos SA, Terpos E (2016) Clinical vertebral fractures following denosumab discontinuation. Endocrine 27:1929\u20131930","journal-title":"Endocrine"},{"key":"357_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4248\/BR201304003","volume":"1","author":"S Adami","year":"2013","unstructured":"Adami S, Idolazzi L, Fracassi E et al (2013) Osteoporosis treatment: when to discontinue and when to re-start. Bone Res 1:323\u2013335","journal-title":"Bone Res"},{"key":"357_CR7","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s00330-007-0684-0","volume":"17","author":"M Libicher","year":"2007","unstructured":"Libicher M, Appelt A, Berger I et al (2007) The intravertebral vacuum phenomenon as specific sign of osteonecrosis in vertebral compression fractures: results from a radiological and histological study. Eur Radiol 17:2248\u20132252","journal-title":"Eur Radiol"},{"key":"357_CR8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00586-012-2618-z","volume":"22","author":"CL Lin","year":"2013","unstructured":"Lin CL, Lin RM, Huang KY et al (2013) MRI fluid sign is reliable in correlation with osteonecrosis after vertebral fractures: a histopathologic study. Eur Spine J 22:1617\u20131623","journal-title":"Eur Spine J"},{"key":"357_CR9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00586-011-1789-3","volume":"20","author":"SW Feng","year":"2011","unstructured":"Feng SW, Chang MC, Wu HT et al (2011) Are intravertebral vacuum phenomena benign lesions? Eur Spine J 20:1341\u20131348","journal-title":"Eur Spine J"},{"key":"357_CR10","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","volume":"26","author":"S Papapoulos","year":"2015","unstructured":"Papapoulos S, Lippuner K, Roux C et al (2015) The effect of 8 or 5\u00a0years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study. Osteoporos Int 26:2773\u20132783","journal-title":"Osteoporos Int"},{"key":"357_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","volume":"41","author":"RS Weinstein","year":"2012","unstructured":"Weinstein RS (2012) Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin N Am 41:595\u2013611","journal-title":"Endocrinol Metab Clin N Am"},{"key":"357_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","volume":"365","author":"RS Weinstein","year":"2011","unstructured":"Weinstein RS (2011) Clinical practice: glucocorticoid-induced bone disease. N Eng J Med 365:62\u201370","journal-title":"N Eng J Med"},{"key":"357_CR13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2012.09.017","volume":"54","author":"SC Manolagas","year":"2013","unstructured":"Manolagas SC, Parfitt AM (2013) For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone 54:272\u2013278","journal-title":"Bone"},{"key":"357_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of Wnt\/b-Catenin signalling in the treatment of osteoporosis. Calcif Tissue Int 93:121\u2013132","journal-title":"Calcif Tissue Int"},{"key":"357_CR15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-014-0196-1","volume":"12","author":"NA Sims","year":"2014","unstructured":"Sims NA, Ng KW (2014) Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib. Curr Osteoporos Rep 12:98\u2013106","journal-title":"Curr Osteoporos Rep"},{"key":"357_CR16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","volume":"29","author":"TL Aghaloo","year":"2014","unstructured":"Aghaloo TL, Cheong S, Bezouglaia O et al (2014) RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J Bone Miner Res 29:843\u2013854","journal-title":"J Bone Miner Res"},{"key":"357_CR17","first-page":"e431","volume":"21","author":"CC Oliveira de","year":"2016","unstructured":"de Oliveira CC, Brizeno LA, de Sousa FB et al (2016) Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (denosumab): review. Med Oral Patol Oral Cir Bucal 21:e431\u2013e439","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"357_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"2","author":"LF Bonewald","year":"2011","unstructured":"Bonewald LF (2011) The amazing osteocyte. J Bone Miner Res 2:229\u2013238","journal-title":"J Bone Miner Res"},{"key":"357_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0288-x","author":"IR Reid","year":"2017","unstructured":"Reid IR, Horne AM, Mihov B, Gamble GD (2017) Bone loss after denosumab: only partial protection with zoledronate. Calcif Tissue Int. \n                        https:\/\/doi.org\/10.1007\/s00223-017-0288-x","journal-title":"Calcif Tissue Int"},{"key":"357_CR20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","volume":"386","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, Tsai JN, Uihlein AV et al (2015) Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet 386:1147\u20131155","journal-title":"Lancet"},{"key":"357_CR21","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","volume":"25","author":"KM Kim","year":"2014","unstructured":"Kim KM, Park W, Oh SY et al (2014) Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int 25:1625\u20131632","journal-title":"Osteoporos Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-017-0357-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T11:25:41Z","timestamp":1519039541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-017-0357-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,4]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1007\/s00223-017-0357-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,4]]}}}